Patent details
EP1390037 Title: USE OF GLUCOCORTICOID RECEPTOR-SPECIFIC ANTAGONISTS FOR THE TREATMENT OF DELIRIUM
Basic Information
- Publication number:
- EP1390037
- PCT Application Number:
- PCT/US/2002/014318
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027316892
- PCT Publication Number:
- WO/2002/096433
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF GLUCOCORTICOID RECEPTOR-SPECIFIC ANTAGONISTS FOR THE TREATMENT OF DELIRIUM
- French Title of Invention:
- UTILISATION D'ANTAGONISTES SPECIFIQUES DU RECEPTEUR DES GLUCOCORTICOIDES POUR LE TRAITEMENT DU DELIRIUM
- German Title of Invention:
- VERWENDUNG VON GLUCOCORTICOID-REZEPTOR-SPEZIFISCHEN ANTAGONISTEN ZUR BEHANDLUNG VON DELIRIUM
- SPC Number:
Dates
- Filing date:
- 06/05/2002
- Grant date:
- 22/12/2010
- EP Publication Date:
- 22/12/2010
- PCT Publication Date:
- 05/12/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/02/2004
- EP B1 Publication Date:
- 22/12/2010
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 06/05/2011
- Expiration date:
- 06/05/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/05/2002
- Name:
- Corcept Therapeutics Inc.
- Address:
- 149 Commonwealth Drive, Menlo Park, CA 94025, United States (US)
Inventor
- Name:
- BELANOFF Joseph, K.
- Address:
- United States (US)
Priority
1
- Priority Number:
- 137800
- Priority Date:
- 19/10/1993
- Priority Country:
- United States (US)
2
- Priority Number:
- 288619 P
- Priority Date:
- 04/05/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/56;
| Filing date | Document type | Number of pages |
|---|